As Seen In...
Dr. Megan Haymart (left) and Dr. Maria Papaleontiou (right) at the AACE 2025 Awards ceremony.
ThyCARE Team Receives Inaugural AACE Endocrine Care Innovation Award in recognition of an outstanding body of work by a team focused on, but not limited to, clinical outcomes or health care delivery platforms.
For more information, click HERE
Left to right: Dr. Debbie Chen, Dr. Nazanene Esfandiari, Dr. Megan Haymart, and Dr. Maria Papaleontiou at the AACE 2025 Award Ceremony
Hossein Gharib MD, Educational Lectureship Award Recipient Megan Haymart, MD
AACE Rising Star in Endocrinology Award Recipient Maria Papaleontiou, MD.
Maria Papaleontiou to help revise hypothyroidism guidelines for American Thyroid Association, February 2023.
Maria Papaleontiou serving as chair of the ATA Women in Thyroidology 2022-2023.
Award selected by the Women in Thyroidology of the American Thyroid Association, given to recognize the outstanding contributions of a woman in thyroidology who has demonstrated a long-standing commitment to the ATA and the advancement of women both within the organization and in the field, granted to Dr. Megan Haymart.
Women Advancing Thyroid Research Award, 2021
This award recognizes and honors the work of young women that are leading outstanding thyroid research. Recipient: Maria Papaleontiou, MD .
Mary Ann Liebert, Inc. Articles
Thyroid Journal, Special Collection on Thyroid Cancer, Two of our team’s manuscripts are top read thyroid cancer articles:
Debbie Chen, abstract titled "Disparities in the overestimation of thyroid cancer risk of recurrence and death" selected as one of the thirty (32) 2019 Trainee Poster Contest finalists and having one of the top scoring trainee abstracts for ATA 2019.
Nazanene Esfandiari, MD, awarded the 2025 Kaiser Permanente Excellence in Teaching (pre-clinical). The Kaiser Award is the most prestigious teaching award given by the Medical School.
2025 ENDO Society Meeting
Maria Papaleontiou presents poster titled "Use of Neck Ultrasound in Older Adults with Thyroid Nodules".
Debbie Chen, notice of Outstanding Abstract Award for ENDO 2023 in Chicago, IL, "Real World Use of Systemic Therapy for Treatment of Advanced Thyroid Cancer.
Debbie Chen, Endocrine Society Outstanding Abstract Award in conjunction with ENDO 2021 for "Unmet Information Needs Among Hispanic Women With Thyroid Cancer".
Megan Haymart, "Thyroid Cancer: How much Surveillance is too Much?"
Rachel Beeson, "Nearly one-third of older thyroid patients take medications that interfere with thyroid function tests"
For more information, click HERE
Maria Papaleontiou, Endocrine Society Press Release: Survey finds physicians struggle to communicate positive prognosis to thyroid cancer patients.
See the full virtual news conference HERE.
Megan Haymart will be featured in a session at ENDO 2020 titled, “You’ve Been Cured of Thyroid Cancer – Now What?” that will focus on the challenges of managing thyroid cancer after treatment.
Mousumi Banerjee receives McDevitt Excellence in Research Award
R01 awarded to Dr. Papaleontiou; Article from AI & Digital Health Innovation
Recipient Dr. Debbie Chen, study titled "Real-World Use of Systemic Therapies for Patients with Advanced Thyroid Cancer".
Mousumi Banerjee, University of Michigan Precision Health Member Spotlight
Recipient, Dr. Megan Haymart.
Dr. Maria Papaleontiou and Dr. Megan Haymart featured in University of Michigan Medical School's MEND Behind the Scenes
Pilot Award: Deprescribing thyroid hormone replacement therapy in older adults with dementia. Receipient, Dr. Maria Papleontiou, MD.
Recipient Maria Papaleontiou, MD.
Megan Haymart, "Clinical context crucial when treating thyroid cancer in older adults"
Megan Haymart, "Choose wisely: Tailor thyroid cancer treatments to minimize harms"
Megan Haymart, "Strategies for surveillance after thyroid cancer ‘cure’ based on treatment type"
Maria Papaleontiou, Perspective on: "‘Get it out’ a common reaction for adults diagnosed with papillary thyroid cancer"
Maria Papaleontiou, "Thyroid Hormone replacement increased and risk of stroke."
For more information, click HERE
Megan Haymart, "Low-risk thyroid cancer diagnoses increasing as ultrasound use rises."
Maria Papaleontiou, "Thyroid surgery complications more common than previously believed, JCEM"
For more information, click HERE
Maria Papaleontiou, "Patient age important in determining TSH goals in hypothyroidism"
Jaime Wiebel, "PET imaging used in about 20% of differentiated thyroid cancers"
Megan Haymart, "Researchers assess radioactive iodine use in medium-risk thyroid cancer"
Thyroid cancer anxiety persists years past diagnosis. Maria Papaleontiou, MD, American Thyroid Association Meeting 2018
Megan Haymart, interview on "Voice Changes Common After Thyroid Surgery"
Josh Evron, MD: Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance, Cancer.
For more information, click HERE and HERE
Palak Choksi: Higher Rates of Bone Metastases and Increased Risk of Death in Follicular and Medullary Thyroid Cancer
Lauren P. Wallner, PhD, MPH, on Thyroid Cancer: Reducing Overtreatment With Radioactive Iodine.
Lauren Wallner, PhD: Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?, JCO
Maria Papaleontiou, "Is Thyroid Cancer a "Good Cancer?"
Megan Haymart, "Many Thyroid Cancer Ultrasound Scans Unnecessary"
Jaime Wiebel, "Postdiagnosis imaging common in thyroid cancer"
Kevin Kovatch, MD: Voice Abnormalities Prevalent After Thyroid Surgery
Maria Papaleontiou, MD: Fracture Risk in Men With Thyroid Cancer, Oncologist
Maria Papaleontiou presented the 34th Boris Catz Lectureship at Cedars-Sinai on April 4, 2025, "Transforming low-value care to value-based care in hypothyroidism".
Maria Papaleontiou presented the Annual Ernest Mazzaferri Lectureship on Thyroid Cancer at the Ohio State University on November 7, 2024, "Thyroid Cancer Care: Lessons Learned and Opportunities for Improvement".
Megan Haymart, presented the Annual Sidney H. Ingbar Lectureship Virtual Medical Grand Rounds on October 13 2022 at Beth Israel Deaconess Medical Center in Boston, Massachusetts, “Thyroid Cancer Management: How can we do better?”.
Megan Haymart, 2nd woman in 32 years to give the Cedars-Sinai Boris Catz lecture to the Department of Internal Medicine, on September 23 2022 in Los Angeles, California, "Questioning Thyroid Cancer Management: How can we do more?".
The Michigan Otolaryngological Society 2018 Resident Recognition Award Program Results. First Place: The 2018 Walter M. Belenky, M.D., Resident Research Award Winner, Kevin J. Kovatch, M.D. - “Abnormal Voice and Vocal Fold Motion Impairment Following Surgery for Thyroid Cancer”
Video Interview with Dr. Megan Haymart and Dr. Mousumi Banerjee, BMJ on Eurekalert!
VIDEO: Radioactive Iodine: To Treat or Not To Treat Low-Risk Thyroid Cancer; The Endocrine Society, ENDO 2016, Megan Haymart
JCEM Press- Featured Author (February 2014), Nazanene Esfandiari